October 26, 2015
Tailoring Treatment, One Cancer Patient at a Time
By Jeff Briggs
This post was originally published last week on Footnote, a website that brings academic research and ideas to a broader audience, as part of a three-part series on how precision medicine is being used today to improve health care treatment for patients. The first article in the series, “Genomics Moves From The Lab To The […]
Tags: BEAUTY, beauty project, BRCA1, BRCA2, breast cancer, center for individualized medicine, Dr. Judy Boughey, Dr. Matthew Goetz, Holly Boehle, individualized medicine, Precision Medicine
August 23, 2013
Breast Cancer: BRCA Test Not the Final Arbiter
By AJ Montpetit
The BRCA1 and BRCA2 genes have become the most well-known breast cancer genes to be tested for due to recent celebrity buzz as well as Supreme Court ruling on the patents on the genes themselves. While getting tested for the BRCA1 and BRCA2 reveals the possibility for a woman to contracting breast cancer, the mutations […]
Tags: brca, BRCA1, BRCA2, breast cancer, cancer, center for individualized medicine, Fergus Couch, Fergus J. Couch, gene sequencing, Genetics, individualized medicine, mayo clinic
August 6, 2013
Promising Markers Discovered for Preventative Breast Cancer Therapy
By Center for Individualized Medicine
Collaboration is a key area of proven scientific discovery at Mayo Clinic, and with an international research team led by investigators from the Center for Individualized Medicine and the National Institute of Health’s Pharmacogenomics Research Network, this team has identified specific single-nucleotide polymorhisms (SNPs) in and near the ZNF423 and CTSO genes that show […]
Tags: BRCA1, breast cancer, center for individualized medicine, estrogen, genes, genetic therapy, Genetics, mayo clinic, national institute of health, pharmacogenomics, preventative therapy, snp